​
​

HTG Molecular Diagnostics (HTGM) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

HTGM Stock Forecast

HTG Molecular Diagnostics stock forecast is as follows: an average price target of $0.17 (represents a -65.28% downside from HTGM’s last price of $0.48) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

HTGM Price Target

The average price target for HTG Molecular Diagnostics (HTGM) is $0.17 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $0.17 to $0.17. This represents a potential -65.28% downside from HTGM's last price of $0.48.

HTGM Analyst Ratings

Buy

According to 1 Wall Street analysts, HTG Molecular Diagnostics's rating consensus is 'Buy'. The analyst rating breakdown for HTGM stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

HTG Molecular Diagnostics Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 15, 2022-H.C. Wainwright$0.17$0.0992.31%-65.28%
Row per page
Go to

The latest HTG Molecular Diagnostics stock forecast, released on Aug 15, 2022 by H.C. Wainwright company, set a price target of $0.17, which represents a 92.31% increase from the stock price at the time of the forecast ($0.09), and a -65.28% decrease from HTGM last price ($0.48).

HTG Molecular Diagnostics Price Target by Period

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.48$0.48$0.48
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of HTG Molecular Diagnostics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to HTG Molecular Diagnostics's last price of $0.48. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 29, 2022H.C. WainwrightBuyBuyHold
Row per page
Go to

HTG Molecular Diagnostics's last stock rating was published by H.C. Wainwright on Dec 29, 2022. The company gave HTGM a "Buy" rating, the same as its previous rate.

HTG Molecular Diagnostics Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TTOOT2 Biosystems$0.51$5.00880.39%Hold
GTHGenetron$4.03$10.00148.14%-
HTGMHTG Molecular Diagnostics$0.48$0.17-64.58%Buy

HTGM Forecast FAQ

Is HTG Molecular Diagnostics a good buy?

Yes, according to 1 Wall Street analysts, HTG Molecular Diagnostics (HTGM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HTGM's total ratings.

What is HTGM's price target?

HTG Molecular Diagnostics (HTGM) average price target is $0.167 with a range of $0.167 to $0.167, implying a -65.28% from its last price of $0.48. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will HTG Molecular Diagnostics stock go up soon?

According to Wall Street analysts' prediction for HTGM stock, the company can go down by -65.28% (from the last price of $0.48 to the average price target of $0.167), down by -65.28% based on the highest stock price target, and down by -65.28% based on the lowest stock price target.

Can HTG Molecular Diagnostics stock reach $1?

HTGM's average twelve months analyst stock price target of $0.167 does not support the claim that HTG Molecular Diagnostics can reach $1 in the near future.